Kristin Fabre

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Fei Li, Changtao Jiang, Kristopher W. Krausz et al. · Nature Communications · 2013 · 690 citations · Full text

Life Sciences, Cell Biology, Pharmacology +14

<i>In vitro</i> and <i>In vivo</i> Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762

James B. Mitchell, Rajani Choudhuri, Kristin Fabre et al. · Clinical Cancer Research · 2010 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications

Kristin Fabre, Brian R. Berridge, William R. Proctor et al. · Lab on a Chip · 2020 · 106 citations

Pharmacy, Toxicology, Biomems +12

On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships

Christopher W. McAleer, Amy Pointon, Christopher J. Long et al. · Scientific Reports · 2019 · 88 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective

Lorna Ewart, Kristin Fabre, Ananthsrinivas Chakilam et al. · Experimental Biology and Medicine · 2017 · 87 citations · Full text

Engineering, Biomedical Engineering, Biotechnology +13